- Home
- Companies
- united kingdom
- pharmaceutical excipients development
Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Defense
- Aerospace & Air Transport
- Glassware
- Paint
- Plastics & Resins
- Chemical & Pharmaceuticals
- Waste and Recycling
- Oil, Gas & Refineries
- Water and Wastewater
- Agriculture
- Environmental
- Health and Safety
- Air and Climate
- Soil and Groundwater
- University / Academia / Research
- Government
- Manufacturing, Other
- Food and Beverage
- Energy
Pharmaceutical Excipients Development Suppliers In United Kingdom
12 companies found
based inLondon, UNITED KINGDOM
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, ...
based inSan Jose, CALIFORNIA (USA)
We provide our customers with innovative bioanalytical solutions for protein and cell biology in life science research, pharmaceutical and biotherapeutic development. With over 140,000 placements in laboratories around the world, our instruments ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Joint venture collaboration. Early development stage completed. IP application filed. Advisers retained to explore commercial ...
based inFlintshire, UNITED KINGDOM
Quay Pharma is an independent, privately owned contract development manufacturing organisation (CDMO). Since 2002 we have proudly delivered over 250 successful projects and exercised continued improvement whilst remaining true to our core values. ...
Quay Pharma is widely recognised as leading experts in all aspects of pharmaceutical development and dosage form optimisation for a wide range of product types, including those that have poor solubility or ...
based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
Hemogenyx Pharmaceuticals utilizes postnatal human hemogenic endothelial cells (Hu-PHEC cells), discovered by Hemogenyx Pharmaceuticals’ Co-Founder Dr Vladislav Sandler, to generate cancer-free hematopoietic stem cells (HSC) for use in ...
based inDarmstadt, GERMANY
Merck: A Leader in Life Science. Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and ...
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...
ReGen Therapeutics was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. The complex and the peptides within it are viewed as having potential utility in neurodegenerative ...
based inSan Clemente, CALIFORNIA (USA)
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. At Glaukos, our focus is to develop and lead the ...
based inMelville, NEW YORK (USA)
Population Bio, Inc. is a privately held precision medicine company that is empowering pharmaceutical companies to develop targeted therapies and companion diagnostics faster and more cost effectively. We are accelerating the delivery of precision ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
There are two XF-73 dermal programmes in development. One is being run by our China partner and shareholder – China Medical Systems Holdings Limited (CMS) – focused on superficial skin infections and the other is an in-house programme ...
based inColwick, UNITED KINGDOM
Copley Scientific was founded in 1946 in Nottingham, UK, by Frank Copley, to supply laboratory equipment to the local pharmaceutical industry. Today, still family owned and managed, we are recognised as the world’s leading manufacturer of inhaler ...
based inAbingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...